BACKGROUND: Singleton infants conceived using assisted reproductive technology have lower average birthweights than naturally conceived infants and are more likely to be born low birthweight (<2500 gr). Lower birthweights are associated with increased infant and child mortality and poor adult health outcomes, including cardiovascular disease, hypertension, and diabetes. Data from registry and single-center studies suggest that frozen/thawed embryo transfer may be associated with larger birthweights. To date, however, a nationwide, full-population study on United States infants born using frozen/thawed embryo transfer has not been reported. OBJECTIVES: The objective of this study was to compare the effect of frozen/thawed vs fresh embryo transfer on birthweight outcomes for singleton, term infants conceived using in vitro fertilization in the United States between 2007 and 2014, including average birthweight and the risks of both macrosomia (>4000 g) and low birthweight (<2500 g). STUDY DESIGN: We used data from the Centers for Disease Control and Prevention's National Assisted Reproductive Technology Surveillance System to compare birthweight outcomes of live-born singleton, autologous oocyte, term (37-43 weeks) infants. Generalized linear models for all infants and stratified by infant sex were used to assess the relationship between frozen/thawed embryo transfer and birthweight, in grams. Infertility diagnosis, year of treatment, maternal age, maternal obstetric history, maternal and paternal race, and infant gestational age and sex were included in the models. Missing race data were imputed. The adjusted relative risks for macrosomia and low birthweight were evaluated using multivariable predicted marginal proportions from logistic regression models. RESULTS: In total, 180,184 singleton, term infants were included, with 55,898 (31.02%) having been conceived from frozen/thawed embryos. Frozen/thawed embryo transfer was associated with, on average, a 142 g increase in birthweight compared with infants born after fresh embryo transfer (P < .001). An interaction between infant sex and embryo transfer type was significant (P < .0001), with frozen/thawed embryo transfer having a larger effect on male infants by 16 g. The adjusted risk of a macrosomic infant was 1.70 times higher (95% confidence interval, 1.64e1.76) following frozen/thawed embryo transfer than fresh embryo transfer. However, adjusted risk of low birthweight following frozen/thawed embryo transfer was 0.52 (95% confidence interval, 0.48e0.56) compared with fresh embryo transfer. CONCLUSION: Frozen/thawed embryo transfer, in comparison with fresh embryo transfer, was associated with increased average birthweight in singleton, autologous oocytes, term infants born in the United States, with a significant interaction between frozen/thawed embryo transfer and infant sex. The risk of macrosomia following frozen/thawed embryo transfer was greater than that following fresh embryo transfer, but the risk of low birthweight among frozen/thawed embryo transfer infants was significantly decreased in comparison with fresh embryo transfer infants.
Key words: birthweight, fresh embryo transfer, frozen/thawed embryo transfer, in vitro fertilization, low birthweight, macrosomia, National ART Surveillance System T he number of infants born following conception using assisted reproductive technologies (ART) has increased by greater than 20% in the past decade, with 70,354 ART-conceived infants born in the United States in 2014. 1 During this time, ART practice and technology has improved, with significant improvements in slow freeze and vitrification technologies, making embryo freezing increasingly more successful 2 and allowing for increased use of embryo banking. 3 There are therefore now many new treatment options for clinicians and their patients when deciding how to approach an in vitro fertilization (IVF) cycle. Frozen/thawed embryo transfer (FET), in which embryos are retrieved and then frozen to allow for transfer at a later date, has seen an 82.5% increase in use in the United States between 2006 and 2012. 4 FET appears to result in similar pregnancy outcomes in comparison with fresh embryo transfer 5, 6 and has also been found to be associated with birthweight increases ranging from 50 to 250 g. 7 IVF-conceived infants are more likely to be of lower birthweights than their naturally conceived peers. 8 Given the importance of birthweight in short-and long-term health outcomes, especially infant, child, and adolescent morbidity and mortality, 9 improving birthweights in ART infants is essential to improving overall ART outcomes.
Single-or multisite studies, both internationally [10] [11] [12] and in the United States, 13 and international registry studies [10] [11] [12] 14 have found increased infant birthweights among singletons following conception using FET and a corresponding decrease in small for gestational age and low birthweight (LBW; <2500 g). 11, 13, 15 However, FET has also been linked to large singleton infants, with increased rates of macrosomia and large for gestational age (>90th percentile of birthweight for gestational age) identified in international single-or multisite studies 10, 16 and registry studies. 5, [17] [18] [19] Larger birthweights have been found to increase risk for morbidity because of stillbirth and sudden infant death syndrome, 20 increase systolic blood pressure in adulthood, 21 and increase risk of overweight as children and adults. 22 In the United States, a recent study by Dunietz et al 23 found fresh transfer infant birthweights for singletons were below the national mean, whereas singleton FET infants' birthweights were above the mean. FET infants also had significantly lower risk of being small for gestational age (<10th percentile) than their naturally conceived peers. 23 This study, though, was limited to 3 states.
The most recent registry-based study of FET birthweight outcomes in the United States included data from 2004-2006 24 and found decreased risk of LBW and increased risk of both macrosomia and large for gestational age following FET in comparison with fresh embryo transfer (ET) singleton infants. Since this time, however, embryo culture to blastocyst and blastocyst cryopreservation has changed 13 and, in turn, significantly improved FET pregnancy outcomes.
Additionally, ART procedures may have differing effects on infants, depending on infant sex, 25 indicating a need for new exploration of birthweight outcomes following FET. Because FET is used more frequently, clarification of how it affects birthweight can help guide clinician practice and help patients make informed decisions regarding their IVF procedures.
In this study, we used the Centers for Disease Control and Prevention's (CDC's) National ART Surveillance System (NASS) data to explore infant birthweight outcomes for term, singleton infants born in the United States between 2007 and 2014 following either fresh ET or FET, including rates of macrosomia and LBW by transfer type. We also examined the interaction between infant sex and frozen/thawed embryo transfer to determine whether birthweight effects varied based on infant sex.
Materials and Methods

Cohort selection
The CDC's NASS data contain a record of ART cycles performed in the United States, with more recent data containing an estimated >98% of cycles performed each year. 26 We included all autologous oocyte ART cycles performed between 2007 and 2014. Cycles prior to 2007 were not included because body mass index (BMI) and maternal smoking data were not collected. In total, 1,008,393 ART cycles, excluding embryo banking and gestational carrier cycles, were performed between 2007 and 2014 ( Figure) .
To establish a cohort of infants with low risk for adverse perinatal outcomes, we restricted to cycles that resulted in the birth of at least 1 term infant (37e43 weeks' gestational age, n ¼ 275,088). Likewise, we further excluded cycles that resulted in multiple births (n ¼ 38,123), cycles using donor oocytes or embryos (n ¼ 32,563), those in which the female patient was >45 years old (n ¼ 205) at cycle start, those involving the transfer of >4 embryos (n ¼ 2669), and multiple gestations that resulted in only 1 infant born (n ¼ 13,260).
Cycles resulting in infants with birthweights 5500 g (n ¼ 49) or 1500 g (n ¼ 71) were excluded because these likely represented extreme outliers for term infants. Also excluded were cycles with missing data on infant sex (n ¼ 981), birthweight (n ¼ 2217), and fresh transfers that occurred on days other than cleavage stage (days 2 or 3) or blastocyst stage (days 5 or 6) (n ¼ 3296). This resulted in total sample size of 181,654 autologous oocyte cycles resulting in live-born, singleton, term infants.
Of this population of infants, 36.8% were missing maternal race/ethnicity and 40.6% were missing paternal race/ Under the assumption that data were missing at random, we used multiple imputation to estimate missing values using a nonparametric method, HOTDECK (SUDAAN 11.0.0). Based on variations in the race/ethnicity distribution between US states, we used state as the clustering variable and included all Relationship between fresh/frozen/ thawed embryo transfer and birthweight
All models were generated using SAS version 9.3 and SUDAAN 11 (Research Triangle Park, NC) statistical software. Generalized linear models were used to examine the impact of embryo transfer type (fresh or frozen/thawed) on infant birthweight in grams as the dependent variable. Demographic, treatment, and obstetric history variables were compared between the FET and fresh ET groups using c 2 tests or Student t tests as appropriate.
Variables that had been a priori established as related to birthweight but where less than 10% of data were missing were included in the models. Models therefore included the following covariates: infant sex, gestational age (days), maternal age (years), year of treatment, nonexclusive infertility diagnosis (male factor, diminished ovarian reserve, uterine factor, history of endometriosis, ovulatory disorder, tubal factor, other cause, and unexplained), whether the mother had undergone previous ART cycles (none, 1e2, or 3), whether the mother had previous miscarriages (yes, no), whether the mother had previous births (none, 1-2, or 3 or more), and maternal and paternal race (including imputed values). Most IVF treatment variables were not reported for the frozen/thawed transfer infants, including the transfer stage (blastocyst, days 5e6; or cleavage, days 2e3), the number of oocytes retrieved, the use of intracytoplasmic sperm injection, and the use of preimplantation genetic diagnosis/ screening, so these variables were unable to be included in the model.
To test for a differential effect of embryo transfer type by infant sex, an interaction term was included in the model. Sex-stratified models were generated to improve interpretability. The adjusted relative risk of both macrosomia and low birthweight by treatment was evaluated using multivariable predicted marginal proportions from logistic regression models and included the same covariates as the linear models. Because maternal BMI was missing for 22% of births, it was not included as a covariate in the adjusted models.
To evaluate the extent to which BMI may confound our estimates, we conducted a sensitivity analysis in which BMI was included as a covariate in the linear and logistic regression models; cases with missing BMI values were excluded from these models. Additionally, to ensure that there were no differences in those whose race/ethnicity data was missing, we performed a sensitivity analysis using participants not missing that data and also performed an analysis with missing race/ethnicity as a variable.
We also performed an interaction test and sensitivity analysis for single embryo transfer (SET) to ensure that there was not an effect of number of embryos transferred and that this variable was not an effect modifier or confounder.
All results were considered significant at an alpha of 0.05. This project was approved by the Institutional Review Board at the CDC.
Results Demographics
A total of 180,184 singleton, live-born, term infants were included in the final models (Table 1) . Of these, 55,898 (31.0%) were conceived from a frozen/ thawed embryo transfer. Infants were born between 37 and 43 weeks' gestation (M, 39.3 weeks, SD, 1.1) to mothers between 18 and 45 years old, with an average maternal age of 33.9 years (SD, 4.2). Maternal BMI was predominantly normal or underweight (62.5%) and most mothers were nonHispanic white (74.4%). Asian or Pacific Islander was the second most common maternal race (12.6%). Paternal race was similarly distributed, with 76.3% of fathers identifying as non-Hispanic white and 10.9% identifying as Asian or Pacific Islander. Very few mothers reported being lifetime smokers (4.6%), but 15.2% of lifetime smoking history data were missing. Of all mothers, 2.3% reported smoking during pregnancy.
Parental infertility diagnosis was recorded nonexclusively, with male factor infertility being the most common diagnosis (40.3%). Among female infertility diagnoses, ovulatory disorder, including polycystic ovaries, was the most common (18.0%), followed by unexplained (15.3%) and tubal factor (14.5%) infertility. For most mothers, this was their first child (66.6%), and the case infant was most often conceived on the first round of ART (46.0%). Almost a All data are presented as number (percentage) of participants except where otherwise specified.
ART, assisted reproductive technologies; BMI, body mass index; ICSI, intracytoplasmic sperm injection.
a Data were not available for some treatment variables for infants conceived using frozen/thawed embryo transfers; b Question was asked only of those who reported having smoked >100 cigarettes in their lifetime;
c No significant differences between the frozen/thawed embryo and fresh embryo groups for these 2 variables. All other variables were significantly different between the groups; d Missing maternal and paternal race data were imputed. For the fresh transfer population, the majority of infants (54.1%) were conceived following blastocyst transfer, 74.4% were conceived using intracytoplasmic sperm injection, and 4.8% had received preimplantation genetic diagnosis/screening. An average of 13.5 oocytes were retrieved for fresh cycle patients. For the overall population, assisted hatching was used in 38.1% of cycles, and 27.5% of all cycles were performed using single embryo transfer. An average of 1.94 embryos were transferred per cycle. The average birthweight of infants was 3399.9 g (SD, 472.4). Of these, 2.6% were LBW and 9.8% were macrosomic (>4000 g). Slightly fewer infants (49.4%) were female than male.
Association of fresh or frozen/ thawed embryo transfer, other IVF treatment factors, obstetric history, and demographic factors with infant birthweight FET was associated with a 142 g increase in birthweight over fresh ET (P < .001, Table 2 ). Independent of transfer type, female infants were 143 g smaller than male infants (P .001) and infant weight increased by 155 g per each additional week of gestation. Birthweight was positively associated with maternal age and negatively associated with cycles having been completed more recently (treatment date by year).
A diagnosis of diminished ovarian reserve was associated with a decrease in infant birthweight, while male factor infertility, endometriosis, and ovulatory disorder were all associated with increased birthweight. Prior use of ART was also associated with increased birthweight, with infants whose mothers had previously had 1e2 cycles or 3 cycles being larger than those whose mothers had not had previous cycles.
Infants whose mothers had had 1 or more prior miscarriages were also larger.
Firstborn children weighed an average of 114 g less than children born to mothers with previous children, but there was no effect of the number of pervious children by category. Finally, infants born to nonHispanic white mothers and to nonHispanic white fathers were all larger than those born to any of the other race categories.
Modification of the effect of fresh or frozen/thawed embryo transfer on birthweight outcomes and stratification by sex A significant interaction between infant sex and fresh/frozen/thawed embryo transfer was also identified (P < .0001). Sex-stratified models revealed that frozen/thawed embryo transfer had a greater effect on male infants' birthweights than it did on female infants' birthweights; male infants born from FET were 150 g larger than male infants born following fresh embryo transfers, whereas female infants born following FETwere 134 g larger than female infants born following fresh embryo transfer. Most of the additional variables in the model that previously had been found to be associated with birthweight were still significant in the stratified models. However, for male infants the association between the mother or father identifying as "other" in the race categories was no longer significant.
For female infants, the mother having had three or more prior ART cycles or a prior miscarriage was no longer significantly associated with birthweight, nor was the mother identifying race as "other" or the father identifying as nonHispanic black. For female infants, a maternal diagnosis of tubal factor infertility or another cause of infertility was significantly associated with increased birthweight.
The effect of frozen/thawed embryo transfer on low birthweight and macrosomia
Infants born following FET were 1.7 times more likely to be macrosomic than infants born following fresh embryo transfer (P .001, Table 3 ) after adjustment for infertility diagnosis, race/ ethnicity, and infant and obstetric characteristics. Likewise, there were significantly fewer LBW infants following FET as compared with fresh transfer (adjusted relative risk [aRR], 0.5, P < .001).
Sensitivity analyses
In models in which BMI was included as a covariate, FET was associated with a decrease of 142.3 g. When stratified by infant sex, a 156.2 g decrease in birthweight was observed in males and a 136.7g decrease was observed in females. The aRR for macrosomia was 1.75 ajog.org
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(95% CI, 1.64e1.76) and the aRR for LBW was 0.52 (95% CI, 0.47e0.57).
Missingness for race/ethnicity data was not significantly associated with birthweight, and estimates were not meaningfully different when the analysis was restricted to those without missing race/ ethnicity. Finally, there was no significant interaction between FET and single embryo transfer. Including SET in the model did not meaningfully change the relationship between birthweight and FET (effect size, 141.98 g). When infants born using SET were examined alone (n ¼ 49,496), the effect of FET was 138.45 g, and when double embryo transfer infants were examined alone (n ¼ 98,063), the effect of FET was 146.80 g.
Comment
In this study, we found a positive association between the use of FET and infant birthweight, with singleton infants born following FET being 142 g heavier than those born following fresh ET. We also found a significant interaction between infant sex and birthweight, indicating that the effect of FET differs, depending on infant sex. Our data indicate that FET has a slightly greater impact on male infants than it does on female infants, with a 16 g difference in effect between the 2 groups. Although this difference is small and unlikely to be clinically significant in terms of the long-term effects of birthweight, the significant interaction is indicative of a potential sex-specific mechanism by which FET affects birthweight and therefore warrants further exploration. Keane et al 10 (2016) recently found an opposite effect of infant sex in their single-clinic study in Australia, with stratification indicating that the effect of FET on birthweight was only significant for female infants, with no apparent effect of FET on birthweight for male infants. Previous work by Kaartinen et al, 25 also in a single clinic, found a greater effect size of FET on female infants than on male infants for embryos transferred on days 2e3 and a trend toward greater birthweights in male infants for conceived with transfers on days 5e6 but no difference in female infants for the later transfer group. In contrast, we found a greater effect on male infants and a significant effect for both sexes in a population-level study. Day-of-transfer data, however, were not available for FET infants in our cohort, and further work is needed to elucidate the differing effects of IVF treatments based on sex and transfer stage.
Our results also indicate that there was a significantly increased risk of macrosomia among FET infants and a concomitant decrease in the risk for LBW. In 2014, the macrosomia rate for the US term infant population was 86 infants per 1000, and the rate of LBW was 31 per 1000. 27 The rate of macrosomia among term fresh ET infants in our study was comparable, at 80 per 1000, as was the rate of LBW in this population, 31 per 1000 infants.
In contrast, the rate of macrosomia among FET infants was 130 per 1000, much higher than the national rates, but the rate of LBW was only 16 infants per 1000. Our results correspond with those from international studies, with risk ratios ranging from 1.29 to 2.05 for macrosomia 18, 19, 28 and from 0.73 to 0.81 for LBW 19, 29, 30 for FET infants in comparison with fresh ET infants. Several US studies have similarly found decreased LBWor small for gestational age 13, 23, 31 in infants conceived following FET.
Additionally, our results support recent sibling-pair findings by Luke et al 32 (2017) , who used Society for Reproductive Technology Clinical Outcomes Reporting System (SART-CORS) data to evaluate the effect of FET on US infants in comparison with siblings conceived using fresh ET. They similarly found an increased risk of macrosomia and decreased risk of low birthweight among infants conceived using FET in comparison with those conceived using fresh ET. The findings of Luke et al, however, are generalizable only to those infants whose mothers used IVF for 2 conceptions, resulting in about 15,000 infants.
Our aim, on the other hand, was to expand this understanding to the entire IVF population across United States, and to that end we used a different methodological approach via a larger cohort study. Although SART-CORS data are very comprehensive, fertility clinic participation is voluntary, and those clinics that do participate (around 80% of fertility programs) may be inherently different from the 20% that choose not Original Research GYNECOLOGY ajog.org to participate, resulting in selection bias. NASS, in contrast, contains data from clinics that report to SART-CORS but also those that choose not to report to SART-CORS. Finally, our study provides evidence of an interaction between FET and infant sex; our results indicate that FET affects male and female infants differently. Participant sex is a critical confounder in all studies and is increasingly being recognized as central to the mechanism of effect of many prenatal exposures.
Limitations of our study include missing treatment information for frozen/thawed embryo transfers, most notably embryo stage, because these data are not routinely collected for these cycles. As a result, we were unable to include variables such as use of intracytoplasmic sperm injection, preimplantation genetic diagnosis/screening, and number of oocytes retrieved in this analysis. We also cannot compare rates of blastocyst or cleavage stage embryo transfer between the fresh and frozen/thawed infants because of missing data for the infants conceived using FET. Although it is possible that more frozen/thawed embryos are transferred at blastocyst stage, previous work by our group found only a 5.3 g effect of blastocyst stage transfer, which is unlikely to be sufficient to create the effect size seen in this study.
We also do not have data on the cryopreservation method used to freeze each embryo, although recent data indicate that the freezing approach may not have an effect on birthweight. 33 The type of cycle (natural or with hormone replacement) is also not available for FET cycles, but given that our cohort contains almost all US infants, we are confident that our effect estimates accurately reflect the true effect in this population. Future work on FET cycle types and cryopreservation is needed to better elucidate what component of FET affects birthweight. Additionally, because of the amount of missing maternal BMI and smoking history data, both known predictors of birthweight, neither variable was included in the model. Finally, paternal age is not currently available in NASS and could not be included in models.
Although our data indicate differences in birthweight outcomes between fresh and frozen/thawed ET, we cannot determine whether these differences are due to the freezing procedure or to underlying characteristics of the patients. For example, FET is also used more often in patients who are at risk for ovarian hyperstimulation syndrome. 34 We also do not have data on chronic or gestational diabetes, a risk factor for macrosomia, or for other pregnancy-related complications that could play a role in the increased macrosomia seen in FET infants.
Although there were significant differences in many demographic, obstetric history, and treatment characteristics between the fresh and frozen/thawed embryo groups, inclusion of many of these variables in the model controls for some of the variability in prognosis between these patients. However, we were also unable to control for variation in clinic use of FET compared with fresh ET because some clinics use differing criteria to determine which patients should freeze all embryos and only be offered FET.
The goal of this study was to establish the relationship between FET and birthweight while controlling for as many confounding factors as possible to be able to isolate that relationship. Because both preterm birth and multiple gestations are linked with many causes and complications that would impair the ability to evaluate the effect of FET on birthweight, we did not include preterm or multiple infants in our analysis.
Preterm birth has also been associated with FET, so outcomes in preterm infants should be examined separately because of the possibility of differing effects on preterm infants. Outcomes in preterm and multiple infants are obviously important, and further work is needed to understand the relationship between IVF procedures and their birthweight outcomes, but that was beyond the scope of our aims with this project.
To our knowledge, this is the first study to explore fresh and frozen/thawed embryo transfer birthweight outcomes for a national population of ART infants for this time period as well as the interaction between sex and FET. Additionally, the wealth of data available in the NASS data allowed for a comprehensive model, controlling for many variables related to birthweight that are not often available.
Overall, our data indicate an increased birthweight following FET when compared with fresh ET. FET infants had an increased risk of macrosomia and a corresponding decrease in risk of LBW. Given the increasing trend toward freeze-all cycles, in which all embryos are frozen for future use, understanding the perinatal risks of FET is essential for selecting patients who are good candidates for this treatment. However, the long-term effects of macrosomia are less well established than those of LBW, so determining whether the apparent trade-off related to FET (fewer LBW infants but more macrosomic infants) is beneficial is not yet possible. Additional studies are needed to fully understand the long-term implications of these risks on ART infants.
Implications and contributions
This study used comprehensive, US national data to examine the relationship between FET and birthweight outcomes with the goal of verifying, in a US fullterm, singleton, autologous population, previous findings indicating that infants conceived using FET may have larger birthweights than those conceived using fresh embryo transfer. FET infants were 142 g heavier than those conceived using fresh embryo transfer, with an even greater effect on male infants. Importantly, FET infants had a 70% increased risk of macrosomia (>4000 g) but a 50% decreased risk of being born low birthweight (<2500 g). Because the longterm effects of macrosomia are less well established than those of LBW, determining the benefit of decreased low birthweight infants at the expense of increased macrosomic infants is not yet possible.
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